2018
DOI: 10.1161/jaha.117.007146
|View full text |Cite
|
Sign up to set email alerts
|

Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
102
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 90 publications
(105 citation statements)
references
References 88 publications
0
102
0
3
Order By: Relevance
“…The described case, stresses the need for an individualized assessment of each patient and potentially favors the direct surgical closure in those who present with recurrent embolization and ASDs. This entails the identi cation of shunts with high-risk morphological features and the utilization of the RoPE score to determine the probability of the shunt being responsible for causing the stroke (5). Surgical closure may offer an extra advantage over device closure by allowing the direct inspection and extraction of a possible embolization source within the left heart not picked-up on preoperative imaging.…”
Section: Discussionmentioning
confidence: 99%
“…The described case, stresses the need for an individualized assessment of each patient and potentially favors the direct surgical closure in those who present with recurrent embolization and ASDs. This entails the identi cation of shunts with high-risk morphological features and the utilization of the RoPE score to determine the probability of the shunt being responsible for causing the stroke (5). Surgical closure may offer an extra advantage over device closure by allowing the direct inspection and extraction of a possible embolization source within the left heart not picked-up on preoperative imaging.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with cryptogenic stroke or transient ischemic attack and PFO diagnosis (Table 1), the ideal secondary prevention has been controversial and extensively debated (Baumgartner et al 2010;Collado et al 2018;Kent et al 2011;Kernan et al 2014;Van Dijk et al 2017;Wein et al 2018). Cryptogenic stroke is defined as a stroke of unknown cause, despite extensive investigations to exclude other etiologies, such as large-vessel atherosclerosis, small-artery disease, carotid dissection, space-occupying lesions, intracerebral hemorrhage and atrial fibrillation.…”
Section: Indications For Transcatheter Closurementioning
confidence: 99%
“…The early randomized trials failed to determine the superiority of percutaneous PFO closure over pharmacotherapy for the secondary prevention of cryptogenic stroke (Collado et al 2018). Various recommendations for percutaneous closure have been reported.…”
Section: Indications For Transcatheter Closurementioning
confidence: 99%
See 1 more Smart Citation
“…22 The REDUCE and RESPECT trials resulted in FDA approval of two PFO occluder devices-the GORE and the Amplatzer, respectively. 22 Transcatheter PFO closure is hailed as a safe procedure with a very low risk of complications. In the RESPECT trial, the risk of serious complications such as tamponade, vascular complications, or thrombus were <1%.…”
Section: Introductionmentioning
confidence: 99%